Working… Menu

FOLFIRINOX Plus PF-04136309 in Patients With Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01413022
Recruitment Status : Completed
First Posted : August 9, 2011
Last Update Posted : September 19, 2016
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Washington University School of Medicine